Momelotinib in VEXAS Syndrome — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(11 sites)
France
CHU d'Angers - Service des Maladies du sang, Angers CHU Estaing - Service d'Hématologie Clinique, Clermont-Ferrand Hôpital Claude Huriez - Service de Médecine Interne, Lille CHU Nantes - Hôtel Dieu - Service d'Hématologie Clinique, Nantes Hôpital Saint Louis - Service hématologie séniors, Paris Last updated December 2025